Additionally, in April 2024, Deflazacort Oral Suspension was launched by Tris Pharma Inc., which is a treatment for Duchenne Muscular Dystrophy. The product is a generic version of Emflaza. These product launches and approvals significantly enhance the sales and production of oral generic products,...
03 Jan 2025 • By Dave Wallace Insud Pharma chief executive Lucas Sigman has moved up to lead the IGBA’s CEO Advisory Committee, replacing Lupin chief Vinita Gupta at the helm. Meanwhile, Apotex president and CEO Allan Oberman has become vice-chair. Bio-Thera Picks Tabuk As Stelara Biosim...
Companies like Akorn Incorporated, Apotex, Beximco Pharma, Cipla Inc., Hikma (Roxane), Mylan N.V., Novartis AG (Sandoz), Sun Pharma (Ranbaxy), Teva Pharmaceuticals, among others, hold the substantial share in the market. Inhalation & Nasal Spray Generic Drugs Market Leaders Akorn, Inc. ...
Chinese pharma firms suffer as generic drug crackdown gathers pace Only 58 drugs have been approved. Chinese pharmaceutical companies are bearing the brunt of the government’s bioequivalence test programme, which aims to improve the quality of generic drugs. These regulations are geared ...
Patent: MONO-, DI- OU OLIGOSIDE UTILISE COMME INHIBITEURS METALLIQUES DANS LA PREPARATION D'AGENTS CIBLES FONCTIONNALISES METAL-CHELATE (MONO-, DI- OR OLIGOSACCHARIDE USED AS METAL INHIBITORS IN THE PREPARATION OF RADIOACTIVE METAL-CHELATE-FUNCTIONALIZED TARGET AGENTS) Estimated Expiration: ⤷ Su...
Gland Pharma Endo International PLC 主要章节简要介绍: 第1章: 定义介绍、主要分类、主要应用及研究方法介绍等。 第2章:全球总体规模,历史及未来几年仿制药注射药物总收入,行业趋势、驱动因素、阻碍因素等。 第3章:全球主要厂商竞争态势,收入、最新动态、未来计划、并购等。 第4章:全球主要分类,历史规模及未来趋势...
expects fewer cuts in 2025 The Federal Reserve lowered on Wednesday its benchmark interest rate by a quarter point while reducing the number of cuts it expects to make in 2025. INSIGHT: US Gulf chems face more freezing spells amid warmer winters Chemical plants and refineries along the Gulf Co...